Harvard stem cell research lead Jonathan Hoggatt joins Moderna as director of hematology

Moderna has poached major stem cell researcher Jonathan Hoggatt, Ph.D., to lead its hematology R&D as it gears up for a future outside of COVID vaccines.

Hoggatt comes from the Harvard Stem Cell Institute where he runs his own research unit, the eponymous Hoggatt Lab, where his team’s research is focused on tissue regeneration and stem cell biology, with a particular focus on translational research to enhance bone marrow transplantation.